Exhibit No. 10.6
Confidential Materials omitted and filed separately with the Securities and
Exchange Commission. Asterisks denote omissions.
EXTENSION OF RESEARCH AND LICENSE AGREEMENT BETWEEN THE
GENERAL HOSPITAL CORPORATION AND BIOTRANSPLANT INCORPORATED,
HAVING AN EFFECTIVE DATE OF JANUARY 1, 1991
This is an extension to the Research and License Agreement between The General
Hospital Corporation doing business as Massachusetts General Hospital
("General") and BioTransplant Incorporated, having an Effective Date of January
1, 1991, as amended from time to time by the parties ("Agreement").
For good and valuable consideration, the parties hereby agree as follows:
1. Notwithstanding paragraph 10.1 the Agreement, the Agreement shall be
extended for an additional five (5) years such that it shall terminate
on January 1, 2006, unless terminated sooner in accordance with the
terms of the Agreement, and all references in the Agreement to the
Agreement having an initial term of ten (10) years are deemed to be
references to the Agreement having an initial term of fifteen (15)
years.
2. Research Payments under paragraph 2.3(a) of the Agreement, for each of
the additional five AGREEMENT YEARS shall be [**] Dollars ($[**]) per
year.
3. Payments due under paragraph 2.6 of the Agreement shall continue for
each of the additional five years.
4. It is understood that the term "tissue" or "tissues" in the Agreement
has included, and shall continue to include, cells.
5. In all other respects the Agreement shall remain in full force and
effect.
6. This Extension is effective as of the date on which it is fully
executed, below.
AGREED TO BY:
BIOTRANSPLANT INCORPORATED THE GENERAL HOSPITAL CORPORATION
By: /s/ XXXXXX XXXXXXXX By: /s/ XXXXX X. XXXXX
------------------- --------------
Name: Xxxxxx Xxxxxxxx, Ph.D. Name: Xxxxx X. Xxxxx, X.X.
Title: President and CEO Title: Director, Office of
Corporate Sponsored
Research and Licensing
Date: October 31, 2000 Date: November 1, 2000
/s/ XXXXX XXXXX
---------------
Xxxxx Xxxxx, M.D. ("Principal Investigator")
Date: November 3, 2000
B I O T R A N S P L A N T
